Key result
Artificial intelligence-enabled technology can address structural gaps in capacity, equity, and precision to successfully implement population-scale cardiovascular screening in Europe.
AI-enabled technology and opportunistic screening of existing medical imaging are proposed as essential tools to close the delivery gap in population-level cardiovascular screening mandated by the EU Safe Hearts Plan.
From mandate to mechanism: Closing the delivery gap in cardiovascular screening Cardiovascular disease is the leading cause of death and disability in the European Union (EU), causing around 1.7 million deaths a year and costing over €282 billion annually. (1) The European Commission’s ‘Safe Hearts Plan’, published on 16th December 2025, is the first comprehensive EU-level strategy to address it. (2,3) Its ambition has been widely welcomed, but commentators have questioned whether it can be delivered in the absence of a clear implementation pathway and sustained funding. (4,5) Here Parker J.,(1,2,3), Jackson T.,(1,3) and Eriksson O (1,4) offer the perspective of a developer of artificial intelligence (AI) technology for cardiovascular image analysis.
No takes yet. Share an insight, caveat, or question.
Jack Parker (2026) conducted an editorial in Cardiovascular disease. Artificial intelligence for cardiovascular image analysis vs. Conventional screening was evaluated. Artificial intelligence-enabled technology can address structural gaps in capacity, equity, and precision to successfully implement population-scale cardiovascular screening in Europe.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: